Clinical trial
A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration…
NCT00168857 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00168857 |
|---|---|
| Title | A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study) |
| Official title | A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare MICARDIS® (Telmisartan) 80 mg Versus COZAAR® (Losartan) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study) |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension, Diabetic Nephropathies |
| Intervention type | Drug |
| Interventions | telmisartan, losartan |
| Enrollment | 860 |
| Start date | Jul 9, 2003 |
| Primary completion | Jun 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Dec 8, 2023 |
| Countries | Argentina, Australia, Brazil, Canada, Mexico, New Zealand, South Korea, Taiwan, Thailand, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: